EyePoint Pharmaceuticals, Inc. — Director's Dealing 2014

Jul 16, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2014-07-15

Reporting Person: Freedman Lori (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-15	Employee Stock Option (right to buy)	$4.47	A	75000	Acquired	2024-07-15	Common Stock (75000)	Direct

Footnotes

F1: The option becomes exercisable in four equal annual installments beginning on the first anniversary of the date of grant.